These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 24951760)

  • 21. Is heart failure with preserved ejection fraction a 'dementia' of the heart?
    Tini G; Cannatà A; Canepa M; Masci PG; Pardini M; Giacca M; Sinagra G; Marchionni N; Del Monte F; Udelson JE; Olivotto I
    Heart Fail Rev; 2022 Mar; 27(2):587-594. PubMed ID: 33907929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.
    Tschöpe C; Van Linthout S; Kherad B
    Curr Cardiol Rep; 2017 Aug; 19(8):70. PubMed ID: 28656481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.
    Hamdani N; Bishu KG; von Frieling-Salewsky M; Redfield MM; Linke WA
    Cardiovasc Res; 2013 Mar; 97(3):464-71. PubMed ID: 23213108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets.
    Severino P; D'Amato A; Prosperi S; Fanisio F; Birtolo LI; Costi B; Netti L; Chimenti C; Lavalle C; Maestrini V; Mancone M; Fedele F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction.
    Tamaki S; Mano T; Sakata Y; Ohtani T; Takeda Y; Kamimura D; Omori Y; Tsukamoto Y; Ikeya Y; Kawai M; Kumanogoh A; Hagihara K; Ishii R; Higashimori M; Kaneko M; Hasuwa H; Miwa T; Yamamoto K; Komuro I
    PLoS One; 2013; 8(7):e68893. PubMed ID: 23894370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart failure with preserved ejection fraction in hypertension.
    Teo LY; Chan LL; Lam CS
    Curr Opin Cardiol; 2016 Jul; 31(4):410-6. PubMed ID: 27070649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction.
    van Empel VP; Mariani J; Borlaug BA; Kaye DM
    J Am Heart Assoc; 2014 Dec; 3(6):e001293. PubMed ID: 25468660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Davila A; Tian Y; Czikora I; Li J; Su H; Huo Y; Patel V; Robinson V; Kapuku G; Weintraub N; Bagi Z
    Circ Heart Fail; 2019 Aug; 12(8):e005762. PubMed ID: 31525084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume Loops.
    Rommel KP; von Roeder M; Oberueck C; Latuscynski K; Besler C; Blazek S; Stiermaier T; Fengler K; Adams V; Sandri M; Linke A; Schuler G; Thiele H; Lurz P
    Circ Heart Fail; 2018 Feb; 11(2):e004121. PubMed ID: 29449367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
    Paulus WJ; Dal Canto E
    JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial Senescence Contributes to Heart Failure With Preserved Ejection Fraction in an Aging Mouse Model.
    Gevaert AB; Shakeri H; Leloup AJ; Van Hove CE; De Meyer GRY; Vrints CJ; Lemmens K; Van Craenenbroeck EM
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart failure with preserved ejection fraction in the elderly: scope of the problem.
    Kaila K; Haykowsky MJ; Thompson RB; Paterson DI
    Heart Fail Rev; 2012 Sep; 17(4-5):555-62. PubMed ID: 21818681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
    Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T
    Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction: roles of systolic function and ventricular distensibility.
    Aizawa Y; Sakata Y; Mano T; Takeda Y; Ohtani T; Tamaki S; Omori Y; Tsukamoto Y; Hirayama A; Komuro I; Yamamoto K
    Circ J; 2011; 75(3):596-602. PubMed ID: 21282875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging.
    Loai S; Cheng HM
    Heart Fail Rev; 2020 Mar; 25(2):305-319. PubMed ID: 31364028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
    Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
    JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial adipose deposition and the development of heart failure with preserved ejection fraction.
    Wu CK; Lee JK; Hsu JC; Su MM; Wu YF; Lin TT; Lan CW; Hwang JJ; Lin LY
    Eur J Heart Fail; 2020 Mar; 22(3):445-454. PubMed ID: 31696627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial reverse remodeling: how far can we rewind?
    Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.